RemeGen’s July 2026 Share Update: H-Share Base Steady, A-Share Buyback Trims Free Float by 13,000 Shares

Bulletin Express08-04

RemeGen Co., Ltd. published its Monthly Return for July 2026, confirming that total authorised/registered capital remained unchanged at 564.48 million shares (RMB1 par value). The split between Hong Kong-listed H shares and Shanghai-listed A shares stood at 208.58 million and 355.90 million, respectively.

Issued H shares were unchanged at 208.58 million, and the company affirmed compliance with the Hong Kong Exchange’s minimum 5 percent public-float requirement for PRC issuers. On the A-share register, RemeGen repurchased 13,000 shares on 30 July at RMB109.86 per share for use in employee equity incentive schemes, reducing outstanding A shares to 355.69 million and lifting treasury shares to 207,144. No new shares were issued, nor were any options, warrants or convertibles exercised during the month.

Three ongoing A-share restricted-stock incentive plans still allow up to 2.18 million shares to be granted or transferred from treasury, following prior lapses and attributions. Post-transaction, RemeGen’s total issued share count (excluding treasury shares) stands at 564.27 million, with treasury holdings representing 0.04 percent of authorised capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment